Taiwan / USA

11-50 employees

Angel

Instant NanoBiosensors Co.,Ltd

Taiwan / USA

11-50 employees

Angel

Taiwan-based Instant NanoBiosensors Co., Ltd. is a startup that specializes in biosensor platform development. The mission of the company’s dynamic and problem-driven R&D team is to advance biomedical research and improve patient care by providing customers with simple, reliable, and cost-effective solutions. Its state-of-the-art fiberoptic particle plasmon resonance (FOPPR) technology offers instant and accurate results for a wide range of detection applications. By combining novel biomarkers with a cutting-edge-biosensing platform, this startup aspires to revolutionize traditional immunoassays and analyses for a more efficient healthcare ecosystem.

Categories

Health Care

Platforms

Keywords

Biotech, Biomarker, Point of Care Testing, Smart HealthCare

About Us

Instant NanoBiosensors Co., Ltd (INB) was founded in 2016 with offices located at Wilmington, Delaware USA and Taipei, Taiwan. We are the ONLY ONE company which provides Light-Sensing Biomarker Analyzer based on patented FOPPR (Optic Particle Plasmon Resonance) technology with assays combining wide linear range (~5 orders), ultra-sensitivity (~fg/ml ) and high specificity (double confirm), as well as the benefits of being instant, simple and accurate. Based on over 10 years of R&D accumulated experience by incorporating microfluidics, biology, chemistry and optoelectronics know-how, we have successfully applied FOPPR technology to develop the world’s first Light-Sensing Biomarker Analyzer with inspection chips of high specificity and sensitivity in Aug 2018. Moreover, we have officially obtained over 30 international patents and released 13 international publications. With only 1 drop of blood, 3 step-applications and 5 minutes to get the result, the platform can fit into the mainstream healthcare system to provide early stage screening tests and monitoring for patient’s conditions during and after treatment. In addition, the latest hand-held Light-Sensing Biomarker Analyzer for Point-of-Care Testing (POCT) is expected to be put on the market in Q1 2020. In the future, inspection analysis for disease biomarker of the patient can be conducted by using hand-held inspection device, while the relevant data may be uploaded to the backend diagnosis cloud platform to realize the vision of “instantaneous inspection” to help the patients reach the goal of further diagnosis and self-healthcare.

Upcoming Plan

We are so excited to be one of 24 globally best startups to participate at MEDICA START-UP PARK in Hall 13/ Stand No. 13E56-17 on Nov.18th to Nov.21st Besides, we will also have a presentation in the MEDICA CONNECTED HEALTHCARE FORUM on Nov.21st. We cordially invite you to visit our booth and get more information about our cutting-edge biomarker analyzers. Also you can check the following link; http://www.instantnano.com/ Expecting a crowd on the exhibition, please schedule a meeting to reduce the waiting times. For an appointment, please contact us by BD@instantnano.com (Emily Liang, Global Business Division). Thank you for your attention and we look forward to seeing you. Please feel free to let us know if you have any inquiry.

Nov 05, 2019

Quotes

"Light Saves Lives"

Founder’s Story

Tony Chung, CEO of Instant NanoBiosensors: Tony had listened to a speech addressed by Prof. Lai-Kwan Chau, who is the inventor of Fiber Optical Particle Plasmon Resonance (FOPPR) technology, at an international seminar held in Feb. 2016 introducing the clinical applications for FOPPR which already had over 20 papers published on the international leading journals. As a result, a thought flashed across his mind: if this FOPPR, which has been researched over 10 years can be commercialized by uniting ICT (Information and Communication Technology) industry with the biochemistry research of the past 20 some years, it may become future competitiveness of Taiwan and secure an important position in the global clinical diagnostics market, based on his belief resulted from his near 20 years of experience in the biomedical industry.

Product Feature

Press Release

Timeline

2019/11

Milestone
Launching Light Sensing POCT at MEDICA 2019 in Germany

2019/06

Event
H. Spectrum & Merck Innovation Lab

2019/06

Event
TRANS 2019

2019/05

Event
Labvolution 2019 in Germany

2019/05

Event
InnoVEX 2019

2019/05

Milestone
Selling the product to Brigham and Women's Hospital

2019/04

Establish
US Office in IRVINE CA

2019/04

Event
Rock the Mic 2019

2019/02

Event
The 6th NRCT-IFS-PERCH-CIC Workshops in Tailand

2019/01

Event
4th BIOMARKER & COMPANION DIAGNOSTICS

2019/01

Event
The International Society for Extracellular Vesicles, ISEV

2018/12

Event
2018 BioGroup Symposium

2018/11

Event
StartUP@Tapei

2018/09

Event
TRANS 2018

2018/08

Milestone
Launching INB-D200 at American Association for Clinical Chemistry in Chicago

2018/06

Event
InnoVEX 2018

2018/05

Event
Asia Nano Forum, ANF

2017/09

Event
TRANS 2017

2016/10

Establish
Headquarters (Taipei Office) Founded

READ MORE

Team

Tony Chug

CEO & Co-founder

Suri Huang

CMO

Emily Liang

International Business Development Manager

Henry Yen

TI Director

Paul Wang

Co-founder

Press Contact

Suri Huang

cmo@instantnano.com

+886-912619006

Press Kit